المؤلفون: M. D. Umerova, S. S. Alyadinova, M. J. Khonjonova, R. A. Balakadasheva, E. E. Menadzhiev, D. I. Kharchuk, D. O. Leus, G. I. Islyamova, M. I. Islyamova, S. L. Abkarimova, D. S. Kasabyan, L. E. Sorokina, М. Д. Умерова, С. С. Алядинова, М. Д. Хонджонова, Р. А. Балакадашева, Э. Э. Менаджиев, Д. И. Харчук, Д. И. Леус, Г. И. Ислямова, М. И. Ислямова, С. Л. Абкаримова, Д. С. Касабян, Л. Е. Сорокина

المصدر: Obstetrics, Gynecology and Reproduction; Vol 17, No 3 (2023); 309-320 ; Акушерство, Гинекология и Репродукция; Vol 17, No 3 (2023); 309-320 ; 2500-3194 ; 2313-7347

مصطلحات موضوعية: микроРНК, pregnancy complications, preeclampsia, PE, fetal growth retardation, FGR, transcriptome, miRNA, осложнения беременности, преэклампсия, ПЭ, задержка роста плода, ЗРП, транскриптом

وصف الملف: application/pdf

Relation: https://www.gynecology.su/jour/article/view/1688/1114; https://www.gynecology.su/jour/article/view/1688/1118; Di Renzo G.C. The great obstetrical syndromes. J Maternal Fetal Neonatal Med. 2018;22(8):633–5. https://doi.org/10.1080/14767050902866804.; Brosens I., Pijnenborg R., Vercruysse L., Romero R. The «Great Obstetrical Syndromes» are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204(3):193–201. https://doi.org/10.1016/j.ajog.2010.08.009.; Радзинский В.Е., Милованов А.П., Ордиянц И.М. и др. Экстраэмбриональные и околоплодные структуры при нормальной и осложненной беременности. Под ред. В.Е. Радзинского, А.П. Милованова. М.: МИА, 2004. 393 с.; Malhotra A., Allison B.J., Castillo-Melendez M. et al. Neonatal morbidities of fetal growth restriction: pathophysiology and impact. Front Endocrinol. 2019;10:55. https://doi.org/10.3389/fendo.2019.00055.; Hafner E., Metzenbauer M., Höfinger D. et al. Placental growth from the first to the second trimester of pregnancy in SGA-foetuses and pre-eclamptic pregnancies compared to normal foetuses. Placenta. 2003;24(4):336–42. https://doi.org/10.1053/plac.2002.0918.; Tsochandaridis M., Nasca L., Toga C., Levy-Mozziconacci A. Circulating microRNAs as clinical biomarkers in the predictions of pregnancy complications. Biomed Res Int. 2015;2015:294954. https://doi.org/10.1155/2015/294954.; Iljas J.D., Guanzon D., Elfeky O. et al. Review: bio-compartmentalization of microRNAs in exosomes during gestational diabetes mellitus. Placenta. 2017;54:76–82. https://doi.org/10.1016/j.placenta.2016.12.002.; Anton L., Olarerin-George A.O., Hogenesch J.B., Elovitz M.A. Placental expression of miR-517a/b and miR-517c contributes to trophoblast dysfunction and preeclampsia. PLoS One. 2015;10(3):e0122707. https://doi.org/10.1371/journal.pone.0122707.; Wang Y., Zhang Y., Wang H. et al. Aberrantly up-regulated miR-20a in pre-eclampsic placenta compromised the proliferative and invasive behaviors of trophoblast cells by targeting forkhead box protein A1. Int J Biol Sci. 2014;10(9):973–82. https://doi.org/10.7150/ijbs.9088.; Peng P., Song H., Xie C. et al. miR-146a-5p-mediated suppression on trophoblast cell progression and epithelial-mesenchymal transition in preeclampsia. Biol Res. 2021;54(1):30. https://doi.org/10.1186/s40659-021-00351-5.; Lip S., Boekschoten M., van Pampus M. et al. 103. Dysregulated circulating microRNAs in preeclampsia: the role of miR-574-5p and miR-1972 in endothelial dysfunction. Pregnancy Hypertens. 2018;13:S22. https://doi.org/10.1016/j.preghy.2018.08.068.; Luque A., Farwati A., Crovetto F. et al. Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy. Sci Rep. 2014;4:4882. https://doi.org/10.1038/srep04882.; Luo R., Shao X., Xu P. et al. MicroRNA-210 contributes to preeclampsia by downregulating potassium channel modulatory factor 1. Hypertension. 2014;64(4):839–45. https://doi.org/10.1161/HYPERTENSIONAHA.114.03530.; Xie N., Jia Z., Li L. miR-320a upregulation contributes to the development of preeclampsia by inhibiting the growth and invasion of trophoblast cells by targeting interleukin 4. Mol Med Rep. 2019;20(4):3256–64. https://doi.org/10.3892/mmr.2019.10574.; Zhong Y., Zhu F., Ding Y. Differential microRNA expression profile in the plasma of preeclampsia and normal pregnancies. Exp Ther Med. 2019;18(1):826–32. https://doi.org/10.3892/etm.2019.7637.; Winger E.E., Reed J.L., Ji X. et al. MicroRNAs isolated from peripheral blood in the first trimester predict spontaneous preterm birth. PLoS One. 2020;15(8):e0236805. https://doi.org/10.1371/journal.pone.0236805.; Kochhar P., Vukku M., Rajashekhar R. et al. MicroRNA signatures associated with fetal growth restriction: a systematic review. Eur J Clin Nutr. 2022;76(8):1088–102. https://doi.org/10.1038/s41430-021-01041-x.; Enquobahrie D.A., Abetew D.F., Sorensen T.K. et al. Placental microRNA expression in pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 2011;204(2):178.e12–21. https://doi.org/10.1016/j.ajog.2010.09.004.; Luo S., Cao N., Tang Y., Gu W. Identification of key microRNAs and genes in preeclampsia by bioinformatics analysis. PLoS One. 2017;12(6):e0178549. https://doi.org/10.1371/journal.pone.0178549.; Wu L., Zhou H., Lin H. et al. Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies. Reproduction. 2012;143(3):389–97. https://doi.org/10.1530/REP-11-0304.; Клинические рекомендации – Преэклампсия. Эклампсия. Отеки, протеинурия и гипертензивные расстройства во время беременности, в родах и послеродовом периоде – 2021-2022-2023 (24.06.2021). М.: Министерство здравоохранения Российской Федерации, 2021. 54 с. Режим доступа: http://disuria.ru/_ld/10/1046_kr21O10O16MZ.pdf. [Дата обращения: 25.05.2023].; Клинические рекомендации – Недостаточный рост плода, требующий предоставления медицинской помощи матери (задержка роста плода) – 2022-2023-2024 (14.02.2022). М.: Министерство здравоохранения Российской Федерации, 2022. 47 с. Режим доступа: http://disuria.ru/_ld/11/1152_kr22O36p5MZ.pdf. [Дата обращения: 25.05.2023].; Inno R., Kikas T., Lillepea K., Laan M. Coordinated expressional landscape of the human placental miRNome and transcriptome. Front Cell Dev Biol. 2021;9:697947. https://doi.org/10.3389/fcell.2021.697947.; Wang W., Feng L., Zhang H. et al. Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17, -20a, and -20b) that target ephrin-B2 and EPHB4 in human placenta. J Clin Endocrinol Metab. 2012;97(6):e1051–e1059. https://doi.org/10.1210/jc.2011-3131.; Zhang C., Li Q., Ren N. et al. Placental miR-106a~363 cluster is dysregulated in preeclamptic placenta. Placenta. 2015;36(2):250–52. https://doi.org/10.1016/j.placenta.2014.11.020.; Ishibashi O., Ohkuchi A., Ali M.M. et al. Hydroxysteroid (17-β) dehydrogenase 1 is dysregulated by miR-210 and miR-518c that are aberrantly expressed in preeclamptic placentas: a novel marker for predicting preeclampsia. Hypertension. 2012;59(2):265–73. https://doi.org/10.1161/HYPERTENSIONAHA.111.180232.; Hromadnikova I., Kotlabova K., Hympanova L., Krofta L. Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood. Thromb Res. 2016;137:12–140. https://doi.org/10.1016/j.thromres.2015.11.032.; https://www.gynecology.su/jour/article/view/1688

الاتاحة: https://www.gynecology.su/jour/article/view/1688
https://doi.org/10.17749/2313-7347/ob.gyn.rep.2023.420